COMPAGNUCCI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 3.448
AS - Asia 2.379
EU - Europa 1.518
SA - Sud America 460
AF - Africa 176
OC - Oceania 5
Totale 7.986
Nazione #
US - Stati Uniti d'America 3.311
SG - Singapore 672
VN - Vietnam 573
IT - Italia 464
HK - Hong Kong 395
CN - Cina 372
BR - Brasile 348
RU - Federazione Russa 322
DE - Germania 124
FR - Francia 115
IE - Irlanda 111
BD - Bangladesh 95
SE - Svezia 83
GB - Regno Unito 79
CA - Canada 73
MA - Marocco 65
IN - India 59
CI - Costa d'Avorio 53
FI - Finlandia 53
MX - Messico 42
AR - Argentina 37
ZA - Sudafrica 31
NL - Olanda 29
PL - Polonia 24
TR - Turchia 24
ES - Italia 23
ID - Indonesia 23
IQ - Iraq 21
JP - Giappone 21
AT - Austria 20
CO - Colombia 17
UA - Ucraina 16
PH - Filippine 14
UZ - Uzbekistan 13
PK - Pakistan 12
SA - Arabia Saudita 12
VE - Venezuela 12
CL - Cile 11
DZ - Algeria 10
EC - Ecuador 10
AE - Emirati Arabi Uniti 8
RO - Romania 8
AL - Albania 7
BO - Bolivia 7
JO - Giordania 7
PY - Paraguay 7
BE - Belgio 6
CH - Svizzera 6
GE - Georgia 6
KR - Corea 6
LT - Lituania 6
PE - Perù 6
JM - Giamaica 5
NP - Nepal 5
TH - Thailandia 5
TW - Taiwan 5
UY - Uruguay 5
IL - Israele 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
DO - Repubblica Dominicana 3
ET - Etiopia 3
GR - Grecia 3
KW - Kuwait 3
MY - Malesia 3
BH - Bahrain 2
EG - Egitto 2
HR - Croazia 2
IR - Iran 2
KE - Kenya 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
GA - Gabon 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
KY - Cayman, isole 1
ME - Montenegro 1
MF - Saint Martin 1
ML - Mali 1
Totale 7.977
Città #
Ashburn 955
Singapore 430
Hong Kong 380
San Jose 315
Chandler 259
Dallas 187
Ho Chi Minh City 179
Hanoi 149
Boardman 105
Dublin 104
Beijing 100
Los Angeles 95
New York 87
The Dalles 81
Lauterbourg 68
Ancona 61
Moscow 57
Council Bluffs 56
Munich 56
Abidjan 53
Hefei 47
Des Moines 45
Fairfield 43
São Paulo 43
Turin 43
Milan 38
Helsinki 36
Chicago 34
Orem 32
Seattle 32
Santa Clara 31
Frankfurt am Main 27
Wilmington 25
Da Nang 24
Montreal 23
Denver 22
Haiphong 22
Lawrence 22
Buffalo 21
Mexico City 21
Princeton 21
Rome 21
Tokyo 20
Warsaw 20
Brooklyn 19
London 19
Chennai 18
Houston 18
Jacksonville 18
Nuremberg 18
Cambridge 17
Toronto 17
Turku 17
Woodbridge 17
Boston 16
Shanghai 16
Stockholm 15
Rio de Janeiro 14
Tolentino 14
Washington 14
Amsterdam 13
Johannesburg 13
Manchester 13
Vienna 13
Atlanta 12
Kazan' 11
Phoenix 11
Poplar 11
Ankara 10
Bắc Ninh 10
Columbus 10
Paris 10
Pune 10
Ann Arbor 9
Biên Hòa 9
Hải Dương 9
Porto Alegre 9
San Francisco 9
Tashkent 9
Belo Horizonte 8
Miano 8
Nha Trang 8
Salt Lake City 8
Shenzhen 8
Thái Nguyên 8
Cagliari 7
Can Tho 7
Cape Town 7
Curitiba 7
Dhaka 7
Jeddah 7
Medellín 7
Miami 7
Mumbai 7
Palermo 7
San Diego 7
Tampa 7
Amman 6
Guangzhou 6
Phủ Lý 6
Totale 5.108
Nome #
Recent advances in three-dimensional electroanatomical mapping guidance for the ablation of complex atrial and ventricular arrhythmias 197
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on a Tertiary-Level Electrophysiology Laboratory in Italy 182
Differences in underlying cardiac substrate among S-ICD recipients and its impact on long-term device-related outcomes: Real-world insights from the iSUSI registry 167
Cardiac imaging in athlete’s heart: The role of the radiologist 162
Pulsed field vs very high-power short-duration radiofrequency ablation for atrial fibrillation: Results of a multicenter, real-world experience 154
Ablation Index Predicts Successful Ablation of Focal Atrial Tachycardia: Results of a Multicenter Study 152
Worldwide Survey of COVID-19-Associated Arrhythmias 144
Myocardial Infarction Without Obstructive Coronary Artery Disease (MINOCA): A Practical Guide for Clinicians 139
Long-Term Outcomes of Near-Zero Radiation Ablation of Paroxysmal Supraventricular Tachycardia: A Comparison With Fluoroscopy-Guided Approach 139
Different Phases of Disease in a Highly Characterized Cohort of Lymphocytic Myocarditis: Clinical and Electrophysiological Characteristics 135
Implantable defibrillator-detected heart failure status predicts ventricular tachyarrhythmias 134
Recurrence of atrial fibrillation post-ablation: which is the most effective approach for detection? 132
Pathophysiology of Typical Atrial Flutter 129
Sports Activity and Arrhythmic Risk in Cardiomyopathies and Channelopathies: A Critical Review of European Guidelines on Sports Cardiology in Patients with Cardiovascular Diseases 129
Myocardial inflammation, sports practice, and sudden cardiac death: 2021 update 129
Acute Kidney Injury Resulting From Hemoglobinuria After Pulsed-Field Ablation in Atrial Fibrillation: Is it Preventable? 124
Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: Real-world data from the extended ELISIR experience 124
Clinical outcomes and predictors of success with Impella weaning in cardiogenic shock: a single-center experience 123
Arrhythmic Mitral Valve Prolapse and Sports Activity: Pathophysiology, Risk Stratification, and Sports Eligibility Assessment 123
Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring With Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy 122
Safety and Efficacy of Stereotactic Arrhythmia Radioablation for the Treatment of Ventricular Tachycardia: A Systematic Review 120
High-power short-duration catheter ablation of atrial fibrillation: is it really a new era? Comparison between new and old radiofrequency contact force–sensing catheters 119
Characteristics and Clinical Value of Electroanatomic Voltage Mapping in Cardiac Amyloidosis 118
Decongestive treatment adjustments in heart failure patients remotely monitored with a multiparametric implantable defibrillators algorithm 118
Microelectrode voltage mapping for substrate assessment in catheter ablation of ventricular tachycardia: A dual-center experience 115
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator 114
Derivation and Validation of a Clinical Score for Predicting Postoperative Atrial Fibrillation in Noncardiac Elective Surgery (the HART Score) 113
Posterior wall ablation for persistent atrial fibrillation: Very-high-power short-duration versus standard-power radiofrequency ablation 113
Efficacy of Catheter Ablation for Atrial Arrhythmias in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy-A Multicenter Study 112
Atrial Flutters in Adults with Congenital Heart Disease 112
Different Phases of Disease in Lymphocytic Myocarditis: Clinical and Electrophysiological Characteristics 111
Endomyocardial biopsy: The forgotten piece in the arrhythmogenic cardiomyopathy puzzle 110
Characteristics of patients with recurrent acute myocardial infarction after MINOCA 109
Angina in 2022: Current Perspectives 105
Cardiac Magnetic Resonance and Cardiac Implantable Electronic Devices: Are They Truly Still "Enemies"? 105
Atrial Flutter in Particular Patient Populations 102
P-Waves Are the Main Clues for Correct ECG Interpretation 101
Intraprocedural PRAETORIAN score for early assessment of S-ICD implantation: A proof-of-concept study 98
Etiology and device therapy in complete atrioventricular block in pediatric and young adult population: Contemporary review and new perspectives 97
Endomyocardial biopsy in the hands of the electrophysiologist: the ‘one-stop shop’ for arrhythmic non-ischaemic cardiomyopathy. Letter regarding the article ‘Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy’ 96
Subcutaneous implantable cardioverter-defibrillator and defibrillation testing: A propensity-matched pilot study 96
Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation 95
Catheter Ablation for Ventricular Tachycardia in Patients With Desmoplakin Cardiomyopathy 94
Forensic perspectives on postmortem CIED interrogation: A systematic review and meta-analysis 93
Age-related differences and associated mid-term outcomes of subcutaneous implantable cardioverter-defibrillators: A propensity-matched analysis from a multicenter European registry 93
A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers 92
Incidence of ventricular arrhythmias related to COVID infection and vaccination in patients with Brugada syndrome: Insights from a large Italian multicenter registry based on continuous rhythm monitoring 92
Technological advances in ventricular tachycardia catheter ablation: the relentless quest for novel solutions to old problems 90
Idiopathic Premature Ventricular Contraction Catheter Ablation, Sedentary Population vs. Athlete’s Populations: Outcomes and Resumption of Sports Activity 90
Myocardial Ischemia/Reperfusion Injury: Molecular Insights, Forensic Perspectives, and Therapeutic Horizons 90
Stepwise endo-/epicardial catheter ablation for atrial fibrillation: The Mediterranea approach 90
National workflow experience with pulsed field ablation for atrial fibrillation: learning curve, efficiency, and safety 89
The Role of Cardiac Resynchronization Therapy for the Management of Functional Mitral Regurgitation 88
Ventricular fibrillation recurrences in successfully shocked out-of-hospital cardiac arrests 88
Implantable loop recorders in patients with Brugada syndrome: the BruLoop study 87
Pulsed-field ablation of atrial fibrillation: kinetics of release of multiple cardiac biomarkers 87
Continuous Rhythm Monitoring With Implanted Loop Recorders in Children and Adolescents With Brugada Syndrome 84
Advancing diagnosis in a cardiac arrest case and suspected MINOCA: the complementary roles of imaging, biopsy, and genetic testing 84
Speckle-tracking global longitudinal strain predicts death and cardiovascular events in patients with systemic sclerosis 83
Direct Epicardial Validation of Posterior Wall Electroporation in Persistent Atrial Fibrillation 82
Pulsed field ablation technology for pulmonary vein and left atrial posterior wall isolation in patients with persistent atrial fibrillation 80
Inflammation on Endomyocardial Biopsy Predicts Risk of MACE in Undefined Left Ventricular Arrhythmogenic Cardiomyopathy 79
Electroanatomic Mapping System and Intracardiac-Echo to Guide Endomyocardial Biopsy 79
Impact of ventricular tachycardia ablation in subcutaneous implantable cardioverter defibrillator carriers: a multicentre, international analysis from the iSUSI project 74
Intracardiac echocardiography-guided pulsed-field ablation for successful ablation of atrial fibrillation: a propensity-matched analysis from a large nationwide multicenter experience 74
Atrial tachyarrhythmia recurrence after cryobaloon ablation: does thickness imply failure? 73
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe 73
Atrial fibrillation cycle-length (AF-CL) inside the pulmonary veins predicts paroxysmal AF ablation success— the INDUCE-AF study 71
Oral Anticoagulation and Factor VIII Replacement Therapy in Patients With Hemophilia Undergoing Pulsed-Field or Radiofrequency Catheter Ablation for Atrial Fibrillation 70
Ventricular arrhythmias in athletes: Role of a comprehensive diagnostic workup 68
One-year outcomes of the Mediterranea technique for longstanding persistent atrial fibrillation 67
The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter-defibrillator 65
Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy 63
Interpretation and management of premature ventricular beats in athletes: An expert opinion document of the Italian Society of Sports Cardiology (SICSPORT) 58
Electrophysiological Phenotype-Genotype Study of Sustained Monomorphic Ventricular Tachycardia in Inherited, High Arrhythmic Risk, Left Ventricular Cardiomyopathy 57
Left ventricular functional recovery after atrial fibrillation catheter ablation in heart failure: a prediction model 52
γ-H2AX: A useful tool to detect DNA damage in sudden cardiac death heart tissues, an experimental study 50
The History of Atrial Flutter Electrophysiology, from Entrainment to Ablation: A 100-Year Experience in the Precision Electrocardiology 48
Differentiating sensor changes in a composite heart failure ICD monitoring index: clinical correlates and implications 34
Does Age Impact Safety and Efficacy During Pulse-Field Ablation for Atrial Fibrillation? 34
Cardiac biomarker temporal dynamics after radiofrequency and pulsed field catheter ablation of atrial fibrillation 17
Determinants of Left Atrial Thrombus in Patients Undergoing Catheter Ablation for Atrial Fibrillation and Atrial Flutter 17
Fascicular tachycardia ablation using optrell mapping catheter: a case report 14
Temporal trends of characteristics and management of patients with suspected MINOCA 14
Mitochondria at the Crossroads of Cardiovascular Disease: Mechanistic Drivers and Emerging Therapeutic Strategies 13
Catheter Ablation of Atrial Fibrillation in Patients With Psoriasis: A Multicenter Study 9
AI-Assisted 3D Intracardiac Echocardiography for Pulsed Field Ablation of Atrial Fibrillation Using a Novel Variable Loop Circular Catheter: A Multicenter Evaluation 9
Brugada Syndrome in Sports Cardiology: An Expert Opinion Statement of the Italian Society of Sports Cardiology (SICSport) 8
Long-Term Risk Assessment in Athletes With Complex Ventricular Arrhythmias 7
The Clinical Significance of Atrial Fibrillation in Non–High-Risk Brugada Syndrome 6
De Novo Pulmonary Vein Isolation by Means of Pulsed Field Versus Conventional Thermal Ablation of Paroxysmal Atrial Fibrillation in Women: Safety, Efficiency, and Efficacy 6
How can we improve on selecting the appropriate therapy in Brugada syndrome? 6
Totale 8.210
Categoria #
all - tutte 35.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.541


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 0 17
2021/2022183 2 10 0 0 57 4 4 10 25 18 16 37
2022/2023743 29 67 38 101 39 115 0 56 158 12 81 47
2023/2024468 66 19 37 47 72 73 5 30 36 28 13 42
2024/20251.445 109 129 54 23 65 37 126 59 233 182 142 286
2025/20265.229 442 325 247 578 470 293 1.024 397 422 503 329 199
Totale 8.210